ConductScience.org, home

Paper27487144

Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer.

Wadosky KM and 1 other. Oncotarget, 2016. Cited by 142 papers, by iCite.

Cite this record

ConductScience Library. Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer. Papers, record 27487144. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27487144

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer.
PubMed
Journal
Oncotarget
PubMed
Year
2016
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
142
iCite
Relative citation ratio, by iCite
4.83
iCite
Revised in PubMed
2024-05-24
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wadosky KMKristine M
2Koochekpour SShahriar

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Androgen AntagonistsMajor topic
Antineoplastic Agents, HormonalMajor topic
Drug Resistance, NeoplasmMajor topic
Prostatic Neoplasms, Castration-ResistantMajor topic
Receptors, AndrogenMajor topic
Animals
Humans
Kallikreins
Male
Mutation
Neoplasm Staging
Phosphorylation
Prostate-Specific Antigen
Risk Factors
Signal Transduction
Treatment Outcome

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA016056NCI NIH HHSUnited StatesP30CA016056PubMed and NIHNIH RePORTER
R21 CA181152NCI NIH HHSUnited StatesR21CA181152PubMed and NIHNIH RePORTER
R21 CA183892NCI NIH HHSUnited StatesR21CA183892PubMed and NIHNIH RePORTER

Download CSV of grants

References183

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110797498Fluorescence in situ hybridization evaluation of c-myc and androgen receptor gene amplification and chromosomal anomalies in prostate cancer in Japanese patients.Prostate2000https://conductscience.org/library/papers/10797498PubMed
214976540Gleason grading and prognostic factors in carcinoma of the prostate.Mod Pathol2004https://conductscience.org/library/papers/14976540PubMed
318182665Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study.J Clin Oncol2008https://conductscience.org/library/papers/18182665PubMed
426000489Integrative clinical genomics of advanced prostate cancer.Cell2015https://conductscience.org/library/papers/26000489PubMed
510569618Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a.J Urol1999https://conductscience.org/library/papers/10569618PubMed
623228172Abiraterone in metastatic prostate cancer without previous chemotherapy.N Engl J Med2013https://conductscience.org/library/papers/23228172PubMed
722872761Regulation of the androgen receptor by post-translational modifications.J Endocrinol2012https://conductscience.org/library/papers/22872761PubMed
818511414Site-specific androgen receptor serine phosphorylation linked to epidermal growth factor-dependent growth of castration-recurrent prostate cancer.J Biol Chem2008https://conductscience.org/library/papers/18511414PubMed
918834855Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.Biochem Biophys Res Commun2008https://conductscience.org/library/papers/18834855PubMed
1020842666Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy.Prostate2011https://conductscience.org/library/papers/20842666PubMed
113353726Molecular cloning of human and rat complementary DNA encoding androgen receptors.Science1988https://conductscience.org/library/papers/3353726PubMed
1221446008A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities.Prostate2011https://conductscience.org/library/papers/21446008PubMed
1320141676NCCN clinical practice guidelines in oncology: prostate cancer.J Natl Compr Canc Netw2010https://conductscience.org/library/papers/20141676PubMed
1417949893An analysis of radical prostatectomy in advanced stage and high-grade prostate cancer.Eur Urol2008https://conductscience.org/library/papers/17949893PubMed
1520124400
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology.
CA Cancer J Clin2010https://conductscience.org/library/papers/20124400PubMed
1623147995miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.Clin Cancer Res2013https://conductscience.org/library/papers/23147995PubMed
1725512207Targeting heat shock proteins in metastatic castration-resistant prostate cancer.Nat Rev Urol2015https://conductscience.org/library/papers/25512207PubMed
1822266859Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.Oncogene2012https://conductscience.org/library/papers/22266859PubMed
1917557956Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions.J Clin Oncol2007https://conductscience.org/library/papers/17557956PubMed
2015046683Ten-year survival in patients with metastatic prostate cancer.Clin Prostate Cancer2003https://conductscience.org/library/papers/15046683PubMed

See all 183 referencesDownload CSV of references

Cited by107

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 142 citations.

PMIDTitleJournalYearIn PapersSource
42941926Potential Molecular Links Between Triclosan Exposure and Prostate Cancer: An Integrative Computational Analysis.Int J Mol Sci2026https://conductscience.org/library/papers/42941926PubMed
42662529Asymmetric cross-reactivity of nuclear receptors reveals an evolutionary buffer between estrogen and androgen signaling.iScience2026https://conductscience.org/library/papers/42662529PubMed
42209670Single-cell and spatial RNA sequencing in prostate cancer.Nat Rev Urol2026https://conductscience.org/library/papers/42209670PubMed
42092921Testosterone and cancers: biological functions, molecular mechanisms and therapy.Mol Cancer2026https://conductscience.org/library/papers/42092921PubMed
42012624LMNB2 promotes prostate cancer progression and epithelial-mesenchymal transition via the Wnt/β-catenin pathway.Discov Oncol2026https://conductscience.org/library/papers/42012624PubMed
41939207Liposomal Delivery Systems for Improved Delivery of Docetaxel Against Prostate Cancer.Int J Nanomedicine2026https://conductscience.org/library/papers/41939207PubMed
41898445Anabolic-Androgenic Steroids Revisited: Structural Biology, Receptor Signaling, and Mechanisms of Anabolic-Androgenic Dissociation.Int J Mol Sci2026https://conductscience.org/library/papers/41898445PubMed
41303628Targeting Prostate Cancer Cells Using Anti-Sortilin and Anti-Syndecan-1 Antibody Drug Conjugates.Int J Mol Sci2025https://conductscience.org/library/papers/41303628PubMed
41228300Pharmacokinetics and Pharmacodynamics of Perfluorooctane Sulfonate (PFOS) and Its Role in the Development and Progression of Prostate, Ovarian and Breast Cancers.Cancers (Basel)2025https://conductscience.org/library/papers/41228300PubMed
41176761Association of Germline Single Nucleotide Polymorphisms in Steroid Hormone Metabolism Pathway With Androgen Deprivation Therapy Prognosis of Prostate Cancer in Chinese Population.Cancer Med2025https://conductscience.org/library/papers/41176761PubMed
40963603
Integrative single-cell and machine learning analysis predicts lactylation-driven therapy resistance in prostate cancer: a molecular docking and experiments-validated framework for treatment optimization.
Front Immunol2025https://conductscience.org/library/papers/40963603PubMed
40868127GSTM5 as a Potential Biomarker for Treatment Resistance in Prostate Cancer.Biomedicines2025https://conductscience.org/library/papers/40868127PubMed
40832004PROTAC technology for prostate cancer treatment.Acta Mater Med2025https://conductscience.org/library/papers/40832004PubMed
40776758Cancer‑associated fibroblasts in human malignancies, with a particular emphasis on sarcomas (Review).Int J Oncol2025https://conductscience.org/library/papers/40776758PubMed
40520577Preclinical development and clinical safety assessment of a synthetic peptide conjugate enabling endogenous antibody binding to promote innate receptor engagement.Mol Ther Oncol2025https://conductscience.org/library/papers/40520577PubMed
40391771Targeting PCNA/AR interaction inhibits AR-mediated signaling in castration resistant prostate cancer cells.Oncotarget2025https://conductscience.org/library/papers/40391771PubMed
40303463Combined Transcriptomic and Epitranscriptomic Profiling Identifies THBS1 as A Regulator of Enzalutamide Resistance in Prostate Cancer.Cancer Heterog Plast2025https://conductscience.org/library/papers/40303463PubMed
39857976Prostate Cancer: A Journey Through Its History and Recent Developments.Cancers (Basel)2025https://conductscience.org/library/papers/39857976PubMed
39351434Therapy resistance in prostate cancer: mechanism, signaling and reversal strategies.Explor Target Antitumor Ther2024https://conductscience.org/library/papers/39351434PubMed
39327674Selective killing of castration-resistant prostate cancer cells by formycin A via the ATF4-CHOP axis.Cancer Sci2024https://conductscience.org/library/papers/39327674PubMed

See all 107 cited byDownload CSV of cited by

Genes39

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
AR367PubTator's text mininghttps://conductscience.org/library/genes/367NCBI Gene
ARV164801PubTator's text mininghttps://conductscience.org/library/genes/64801NCBI Gene
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
CRH1392PubTator's text mininghttps://conductscience.org/library/genes/1392NCBI Gene
CYP11A11583PubTator's text mininghttps://conductscience.org/library/genes/1583NCBI Gene
CYP17A11586PubTator's text mininghttps://conductscience.org/library/genes/1586NCBI Gene
EGF1950PubTator's text mininghttps://conductscience.org/library/genes/1950NCBI Gene
FKBP52289PubTator's text mininghttps://conductscience.org/library/genes/2289NCBI Gene
GDE151573PubTator's text mininghttps://conductscience.org/library/genes/51573NCBI Gene
GNRH12796PubTator's text mininghttps://conductscience.org/library/genes/2796NCBI Gene
IGF13479PubTator's text mininghttps://conductscience.org/library/genes/3479NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene
KLK3354PubTator's text mininghttps://conductscience.org/library/genes/354NCBI Gene
MIR143406935PubTator's text mininghttps://conductscience.org/library/genes/406935NCBI Gene
MIR200C406985PubTator's text mininghttps://conductscience.org/library/genes/406985NCBI Gene
MIR21406991PubTator's text mininghttps://conductscience.org/library/genes/406991NCBI Gene
MIR34A407040PubTator's text mininghttps://conductscience.org/library/genes/407040NCBI Gene

See all 39 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/27487144

GET https://conductscience.org/api/papers/v1/27487144/references?page=2